Skip to main content

Current Duke Appointments & Affiliations


Recent Scholarly Works


Patient-Centered Evaluation of Anticoagulation in Atrial Fibrillation.

Journal article NEJM Evid · June 2026 BACKGROUND: Prior analyses of trials comparing direct oral anticoagulants (DOACs) to warfarin in atrial fibrillation (AF) have not routinely incorporated patient preferences, despite substantial variation in how patients value the trade-off between outcome ... Full text Link to item Cite

Evaluating the performance of a resampling approach for internally validating the association between a time-dependent binary indicator and time-to-event outcome.

Journal article J Biopharm Stat · October 2025 Identifying clinical or biological risk factors for disease plays a critical role in enabling earlier disease diagnosis, prognostic outcomes assessment, and may inform disease prevention or monitoring practices. One framework commonly examined is understan ... Full text Link to item Cite

Treatment Patterns, Efficacy, and Tolerability of Belantamab Mafodotin in Patients With Relapsed and/or Refractory Multiple Myeloma: A Real-World Analysis.

Journal article Clinical lymphoma, myeloma & leukemia · August 2025 PurposeBelantamab mafodotin is an anti-B cell maturation antigen (BCMA) immunoconjugate for patients with relapsed/refractory multiple myeloma (RRMM). Additional data on its treatment patterns, efficacy, and tolerability in real-world settings are ... Full text Cite
View All Scholarly Works